ASND Q1 2026 Earnings EPS Misses Estimates as Ascendis Pharma Navigates Cost Pressures Catalyst Pharmaceuticals CPRX Q1 2026 Earnings EPS Beat Signals Operational Strength Amid Quiet Revenue Reporting CATO Q4 2025 Earnings Reported Loss of 055 Per Share Shares Decline 64 Energy Transfer ET Q1 2026 Earnings EPS Miss Slightly Shares Edge Higher Amid Operational Strength Oppenheimer Holdings Inc Q1 2025 Earnings Solid EPS Amid Quiet Revenue Disclosure Stock Slips Gilat Satellite Networks Q1 2026 Earnings Stellar EPS Surprise of 341 Drives Stock Higher